News

Latest News:

mc2_news-image-icon-07

MC2 Therapeutics Announces Approval of Wynzora® Cream in Canada

POSTED: December 19, 2025

MC2 Therapeutics Announces Approval of Wynzora® Cream in Canada

Copenhagen, December 18, 2026 – MC2 Therapeutics, a commercial-stage pharmaceutical company focused on topical therapies in inflammatory skin conditions, today announced that their ...

READ FULL ARTICLE >

mc2_news-image-icon-07

MC2 Therapeutics Appoints Trine Ahlgreen as New CEO

POSTED: May 27, 2025

Copenhagen, May 27th, 2025 – MC2 Therapeutics, a commercial-stage pharmaceutical company focused on topical therapies in inflammatory skin conditions, today announced the appointment of Trine Ahlgreen as Chief Executive Officer, marking ...

READ FULL ARTICLE >